CBKX Pharma SRL
1.7 FTECBKX Pharma reported total assets of 775,561 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Aug 2026), with 1.7 full-time equivalent.
The score of CBKX Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +63 % Total assets -6 % Headcount (avg FTE) +89 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
CBKX Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 51,547 € | ||||
| Equity | 273,094 € | ||||
| Cash | 101,354 € | ||||
| EBITDA | 122,018 € | ||||
| Total assets | 775,561 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 26 Aug 2022
CBKX Pharma's financial analysis
- Solvency35.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of CBKX Pharma
CBKX Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0749.625.106
- VAT number
- BE0749625106
- Peppol
- Registered · 0208:0749625106 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Jul 2020
- Registered office
- 9040 Ghent
- Size
- Micro · 1.7 FTE
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
CBKX Pharma (SRL) has been based in Ghent since 2020, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 51,547 € and equity of 273,094 €; its revenue is not published. With 1.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 35.2%, below the median of its sector (44.2%).
Companies similar to CBKX Pharma
Companies in the same business, of comparable size and area, outside its group.
- Frapeja Pharma Retail sale of pharmaceutical products Ghent · balance sheet 772,946 €
- Brehophar Retail sale of pharmaceutical products Oostkamp · balance sheet 775,082 €
- D’hONDT FARMA Retail sale of pharmaceutical products Hamme (Vl.) · balance sheet 776,363 €
- Pharmacie Van Leeuw Maréchal Retail sale of pharmaceutical products Bassenge · balance sheet 774,546 €
- Pharma Petite Suisse Retail sale of pharmaceutical products Ixelles · balance sheet 776,775 €
- Apotheek Mees Geetbets Retail sale of pharmaceutical products Geetbets · balance sheet 777,058 €
- Deraphar Retail sale of pharmaceutical products Zelzate · balance sheet 778,926 €
- Pharmacies GOFFIN Retail sale of pharmaceutical products Liège · balance sheet 771,286 €
Frequently asked questions about CBKX Pharma
What is the revenue of CBKX Pharma?
CBKX Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of CBKX Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0749625106 for CBKX Pharma, if the company is VAT-registered. Its company number (CBE) is 0749.625.106.
Where is the registered office of CBKX Pharma?
According to the CBE register, the registered office of CBKX Pharma is in 9040 Ghent.
What is the equity of CBKX Pharma?
At the close of the 2025 financial year, the equity of CBKX Pharma amounts to 273,094 €, a solvency of 35.2% of total assets.
How many people work at CBKX Pharma?
1.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages CBKX Pharma?
The register lists 1 active mandates at CBKX Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of CBKX Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →